共 21 条
[2]
N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide(PF-03716556),a novel,potent,and selective acid pump antagonist for the treatment of gastroesophageal reflux disease. Mori H,Tonai-Kachi H,Ochi Y,et al. Journal of Pharmacology and Experimental Therapeutics . 2009
[3]
Gastroprotective effects of the insulin sensitizers,rosiglitazone and metformin,in indomethacin-induced gastric ulcer in type2diabetic rats. Morsy MA,Ashour OM,Fouad AA,et al. Clinical and Experimental Pharmacology and Physiology . 2009
[7]
Dexlansoprazole,a modified release formulation of an enantiomer of lansoprazole,for the treatment of reflux esophagitis. Fock KM,Ang TL. Current Opinion in Investigational Drugs . 2008
[8]
Soraprazan: setting new standards in inhibition of gastric acid secretion. WA Simon,M Herrmann,T Klein,JM Shin,R Huber,J Senn-Bilfinger,S Postius. Journal of Pharmacology and Experimental Therapeutics . 2007
[9]
Systematic review: the global incidence and prevalence of peptic ulcer disease. Sung JJ,Kuipers EJ,El-Serag HB. Alimentary Pharmacology and Therapeutics . 2009
[10]
A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine. Lin J,Huang WW. World Journal of Gastroenterology .